Literature DB >> 11052331

Hepatitis C virus infection and lymphoproliferative disorders.

L R Peña1, S Nand, N De Maria, D H Van Thiel.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11052331     DOI： 10.1023/a:1005557506221

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  52 in total

1.  Cryoglobulinaemia associated with hepatitis C virus infection: a report of 13 cases.

Authors:  B Taillan; P Ferrari; E Ferrari; J G Fuzibet; A Pesce; J F Quaranta; P Dujardin
Journal:  J Intern Med       Date:  1992-10       Impact factor: 8.989

2.  Failure of cyclosporin therapy in type II mixed cryoglobulinemia associated with hepatitis C virus infection.

Authors:  Y Horsmans; D Tennstedt; C Cornu; A P Geubel
Journal:  Clin Exp Rheumatol       Date:  1998 Jul-Aug       Impact factor: 4.473

3.  Fludarabine in the treatment of essential mixed cryoglobulinaemia.

Authors:  F Zaja
Journal:  Eur J Haematol       Date:  1996-09       Impact factor: 2.997

4.  Association between hepatitis C virus and mixed cryoglobulinemia [see comment].

Authors:  C Ferri; F Greco; G Longombardo; P Palla; A Moretti; E Marzo; A Mazzoni; G Pasero; S Bombardieri; P Highfield
Journal:  Clin Exp Rheumatol       Date:  1991 Nov-Dec       Impact factor: 4.473

Review 5.  Viruses and cancers: possible role of hepatitis C virus.

Authors:  C Ferri; L La Civita; A L Zignego; G Pasero
Journal:  Eur J Clin Invest       Date:  1997-09       Impact factor: 4.686

6.  Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia.

Authors:  D Sansonno; S De Vita; A R Iacobelli; V Cornacchiulo; M Boiocchi; F Dammacco
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

7.  Hepatitis C virus infection in patients with essential mixed cryoglobulinemia.

Authors:  R Misiani; P Bellavita; D Fenili; G Borelli; D Marchesi; M Massazza; G Vendramin; B Comotti; E Tanzi; G Scudeller
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

8.  Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

Authors:  M Luppi; G Longo; M G Ferrari; P Barozzi; R Marasca; M Morselli; C Valenti; T Mascia; L Vandelli; D Vallisa; L Cavanna; G Torelli
Journal:  Ann Oncol       Date:  1998-05       Impact factor: 32.976

9.  Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection.

Authors:  V S Wong; W Egner; T Elsey; D Brown; G J Alexander
Journal:  Clin Exp Immunol       Date:  1996-04       Impact factor: 4.330

10.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113
View more
  4 in total

Review 1.  Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?

Authors:  Tawfik Khoury; Shmuel Chen; Tomer Adar; E Ollech Jacob; Meir Mizrahi
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

2.  Non-enveloped HCV core protein as constitutive antigen of cold-precipitable immune complexes in type II mixed cryoglobulinaemia.

Authors:  D Sansonno; G Lauletta; L Nisi; P Gatti; F Pesola; N Pansini; F Dammacco
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways.

Authors:  Youxing Li; Qi Zhang; Yin Liu; Zhen Luo; Lei Kang; Jing Qu; Weiyong Liu; Xueshan Xia; Yingle Liu; Kailang Wu; Jianguo Wu
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

Review 4.  Hepatitis C virus and autoimmunity.

Authors:  Barbara C Böckle; Norbert T Sepp
Journal:  Auto Immun Highlights       Date:  2010-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.